Literature DB >> 28700563

The relationship between serum levels of prolactin and growth hormone in the early postnatal period.

Jonathan Daliot1, Tami Laron-Kenet2, Mohammad Wattad3, Anat Ben-Dor3, Pearl Lilos1, Zvi Laron1.   

Abstract

BackgroundIn the neonatal period, the pituitary hormones including prolactin (PRL) and human growth hormone (hGH) are secreted in high amounts due to immature feedback mechanisms. As both hormones are secreted in part by the same somatomammotrophic cells, we investigated their relationship in newborns with respect to sex, gestational week, method of delivery, and anthropometric data.MethodsThe serum levels of PRL and hGH were measured in blood drawn from 225 newborns. The newborn data were extracted from medical records.ResultsA positive correlation was found between log-transformations of PRL and hGH (r=0.17; P=0.01; n=225), with a stronger correlation in newborns whose blood samples were taken more than 2 days after birth (r=0.42; P<0.001; n=130). Log-transformations of the PRL/hGH ratio demonstrated a positive correlation with the gestational week (r=0.39; P<0.001; n=200). Multiple regression analysis showed that 15% of the variance in the logarithm of this ratio is attributed to the gestational week.ConclusionIn newborns, serum PRL and hGH levels show a positive correlation that can be explained by common regulatory factors or a drift phenomenon. A higher gestational week is associated with a higher PRL/hGH ratio. Further studies are needed to look for possible confounders and to determine the PRL-hGH relationship in different conditions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28700563     DOI: 10.1038/pr.2017.164

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  27 in total

Review 1.  Role of thyrotropin-releasing hormone in prolactin-producing cell models.

Authors:  Haruhiko Kanasaki; Aki Oride; Tselmeg Mijiddorj; Satoru Kyo
Journal:  Neuropeptides       Date:  2015-08-05       Impact factor: 3.286

2.  Human fetal adenohypophysis. Histologic and immunocytochemical analysis.

Authors:  S L Asa; K Kovacs; F A Laszlo; I Domokos; C Ezrin
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

3.  A case of fugitive acromegaly, initially presented as invasive prolactinoma.

Authors:  Jung Soo Lim; Cheol Ryong Ku; Mi-Kyung Lee; Tai Seung Kim; Sun Ho Kim; Eun Jig Lee
Journal:  Endocrine       Date:  2010-04-24       Impact factor: 3.633

4.  Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease.

Authors:  N A Aziz; H Pijl; M Frölich; F Roelfsema; R A C Roos
Journal:  J Neuroendocrinol       Date:  2011-06       Impact factor: 3.627

5.  Diurnal secretion of ghrelin, growth hormone, insulin binding proteins, and prolactin in normal weight and overweight subjects with and without the night eating syndrome.

Authors:  Grethe S Birketvedt; Allan Geliebter; Ingrid Kristiansen; Yngve Firgenschau; Rasmus Goll; Jon R Florholmen
Journal:  Appetite       Date:  2012-07-27       Impact factor: 3.868

Review 6.  Measuring growth hormone and insulin-like growth factor-I in infants: what is normal?

Authors:  Colin Patrick Hawkes; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2013-12

7.  Effect of octreotide on 24-hour growth hormone and prolactin secretory patterns in acromegalics.

Authors:  B Schindel; I Ashkenazi; R Keret; A Silbergeld; M Wasserman; M Lapidot; A G Harris; Z Laron
Journal:  Horm Res       Date:  1991

8.  Transformation of a microprolactinoma into a mixed growth hormone and prolactin-secreting pituitary adenoma.

Authors:  Cédric Dessimoz; Patrick Browaeys; Philippe Maeder; Benoît Lhermitte; Nelly Pitteloud; Shahan Momjian; François P Pralong
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-12       Impact factor: 5.555

9.  Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.

Authors:  Kaja Tikk; Disorn Sookthai; Renée T Fortner; Theron Johnson; Sabina Rinaldi; Isabelle Romieu; Anne Tjønneland; Anja Olsen; Kim Overvad; Françoise Clavel-Chapelon; Laura Baglietto; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Giovanna Masala; Vittorio Krogh; Rosario Tumino; Fulvio Ricceri; Amalia Mattiello; Antonio Agudo; Virginia Menéndez; María-José Sánchez; Pilar Amiano; Maria-Dolores Chirlaque; Aurelio Barricarte; H Bas Bueno-de-Mesquita; Evelyn M Monninkhof; N Charlotte Onland-Moret; Anne Andresson; Malin Sund; Elisabete Weiderpass; Kay-Tee Khaw; Timothy J Key; Ruth C Travis; Melissa A Merritt; Elio Riboli; Laure Dossus; Rudolf Kaaks
Journal:  Breast Cancer Res       Date:  2015-03-31       Impact factor: 6.466

Review 10.  Growth hormone treatment and risk of malignancy.

Authors:  Hyun-Wook Chae; Duk-Hee Kim; Ho-Seong Kim
Journal:  Korean J Pediatr       Date:  2015-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.